Oura 2026: Ring 5 Launches Days After Confidential IPO Filing
Oura launched its Ring 5 on May 28, just one week after filing confidentially for a US IPO at an $11 billion valuation. The 40%-smaller device, paired with blood-pressure and GLP-1 features, repositions the Finnish maker as a health-platform business ahead of Wall Street scrutiny.
David focuses on AI, quantum computing, automation, robotics, and AI applications in media. Expert in next-generation computing technologies.
LONDON, Friday, June 5, 2026 — Oura launched its Ring 5 on May 28, just seven days after filing confidentially with the US Securities and Exchange Commission for an initial public offering at an $11 billion valuation. The Finnish company said the device is 40% smaller than its predecessor and starts at $399, with shipments beginning June 4. Oura Health Oy confirmed the IPO paperwork filing on May 21, looking to capitalize on the growing popularity of wearable devices. CEO Tom Hale told CNBC the company is tracking toward roughly $2 billion in 2026 revenue and expects to surpass five million paid members this quarter. Technical specifications confirmed through official vendor documentation and independent testing.
Key Takeaways
- Oura filed a confidential Form S-1 with the SEC on May 21, 2026, seven months after a $900 million Series E at an $11 billion valuation.
- The Ring 5 is 40% smaller, adds Blood Pressure Signals and Nighttime Breathing, and ships June 4 at $399 (premium finishes $499).
- Samsung's Galaxy Ring 2 is now widely expected to slip to early 2027 amid an active patent dispute with Oura.
- Oura is on track to exceed five million paid members this quarter — a fourfold jump over two years — at an 80% renewal rate.
- Competitive pressure is intensifying: Whoop raised $575 million at a $10.1 billion valuation in March; Garmin reported 42% fitness revenue growth in Q1 2026.
Context & Analysis
The pairing of an IPO filing with a flagship hardware launch is no accident. Oura confidentially filed for an IPO with the SEC seven months after securing a $900 million investment that boosted its valuation to around $11 billion. The Ring 5 reveal one week later gives bankers a fresher revenue story to anchor the offering.
Hardware alone is no longer the pitch. Analysts view the shift from hardware maker to subscription-based health platform as central to its IPO narrative, as the company is currently on track to exceed 5 million paying members. Hale cited a subscription renewal rate among members of 80% — a metric closer to enterprise SaaS than consumer electronics.
The category context matters. The category, popularized by the Finnish brand Oura Health Oy, is on track for a 49% jump in shipments in 2025, according to IDC data shared with Bloomberg, far outpacing an estimated 6% gain by smartwatches. Rivals have moved faster than Oura expected. New products from subscription-free rivals like RingConn and Ultrahuman have increased the pressure to innovate, which likely explains why Oura is launching a new ring just a year and a half after the Ring 4, compared with the roughly three-year gap between the Ring 3 and Ring 4.
| Company | Position | Recent Move | Source |
|---|---|---|---|
| Oura | Smart ring leader | Ring 5 launch + S-1 filing | Oura press release |
| Samsung | No. 2 smart ring | Galaxy Ring 2 delayed; ITC complaint pending | SamMobile |
| Ultrahuman | Subscription-free challenger | Ring PRO shipping at $479 with 15-day battery claim | The Gadgeteer |
| RingConn | Value challenger | Gen 3 shipping immediately after Oura's reveal | TechCrunch |
Related: Wearables R&D Surges: Apple, Samsung, Google Advance Sensors and On-Device AI
Competitive Landscape
Samsung's window is narrowing. Samsung is reportedly re-evaluating its strategy for the Galaxy Ring 2 as it has filed a new lawsuit against Oura, a top rival. Don't expect a Galaxy Ring 2 at the Galaxy S26's Unpacked event. Oura filed a complaint with the US International Trade Commission to request a sales ban on the Galaxy Ring, raising the stakes for both sides.
Related: Global Wearables Outlook 2026: Enterprise Adoption Accelerates
Smartwatch incumbents are not standing still. Apple has continued to add health features to the Apple Watch, while Garmin said it saw a 42% increase in fitness product revenue in its first quarter of 2026 compared to last year, because of strong demand for advanced wearables. The Whoop comparable is the cleanest read on private-market appetite. Whoop, also named to the 2026 CNBC Disruptor 50 list, raised $575 million in Series G funding at a $10.1 billion valuation in March. The implementation approach emphasizes earning HIPAA compliance certification for healthcare applications,
| Company | Category | Key Development | Impact |
|---|---|---|---|
| Apple | Smartwatch | Hypertension detection in Watch lineup | Adds blood-pressure pressure on Oura |
| Garmin | Sport wearables | +42% Q1 2026 fitness revenue | Premium segment intact |
| Whoop | Subscription band | $575M Series G at $10.1B | Validates platform thesis |
| Samsung | Smart ring | Ring 2 slipping to 2027 | Cedes ~8 months of market share |
| Meta | Smart glasses | Up to five wearables planned in 2026 | Diversifies category competition |
Additional coverage: Inside Apple's 2026 Health Wearables Push — And What Garmin and Samsung
Product Substance, Not Just Spec Bumps
The Ring 5's headline addition is Health Radar. Designed in collaboration with more than 40 in-house M.D.s and Ph.D.s, Oura unveiled Health Radar with two foundational capabilities — blood pressure signals and nighttime breathing — giving members clearer guidance on when rest, lifestyle adjustments, or evaluation by a healthcare professional may be warranted. Blood Pressure Signals tracks cardiovascular-related trends using nighttime photoplethysmography data from the smart ring during 30-day assessment periods.
For deeper context, see our Wearables analysis: "Samsung Pilots Galaxy Ring With Insurers as Wearables PoCs Accelerate".
Oura is also pushing into care delivery. The company is building out a connected care infrastructure by integrating an on-demand, AI-enabled clinical triage layer via Counsel Health, allowing users in 43 U.S. states to text licensed physicians directly inside the app. To access this, members will have to pay an additional fee on top of the standard $5.99 monthly subscription, though Oura did not say how much the added service will cost.
Critically for installed-base economics, the marquee software features — Health Radar, blood pressure signals, nighttime breathing, GLP-1 insights and live activity — are rolling out to the Gen 3 and later, not just the Ring 5. If you already own a Ring 4, you are getting almost everything new for free through a software update. That preserves subscription revenue but blunts hardware upgrade incentives.
For deeper context, see our related analysis: "Enterprise Wearables Move From Pilots to Core Infrastructure".
Additional coverage: Top Wearables Enterprise Integration Strategies for 2026, According to Apple, Google and Samsung
What It Means
For Enterprise Buyers
Corporate wellness and benefits teams now have a credible non-watch option with FSA/HSA eligibility. Oura Ring 5, Oura Ring 5 Charging Case, and Oura Membership are HSA- and FSA-eligible. The Counsel Health integration brings triage-grade care into the workflow, reducing the gap between consumer data and clinician escalation. Procurement teams should weigh the recurring $5.99 membership fee against Samsung's no-subscription Galaxy Ring before standardizing.
For Investors
The S-1 timing tells the story: Oura wants the Ring 5 numbers in the comps when the prospectus goes public. Hale forecast that the company would achieve $2 billion in annual revenue in 2026, up from $500 million two years earlier. A 4x revenue run-rate plus 80% subscription renewal is the kind of profile public-market investors will price closer to software than hardware — provided the GLP-1 and blood-pressure features clear FDA scrutiny and competitive pressure from Apple does not compress margins.
Related: Global Wearables Outlook 2026: Enterprise Adoption Accelerates
Related: Enterprise Wearables Move From Pilots to Core Infrastructure
Forward Outlook
Watch three milestones. First, the SEC review timeline: a public S-1 unveiling typically follows the confidential filing by 60–90 days, setting up a possible Q3 or Q4 2026 listing. Second, the rollout of Health Radar beyond the US, India and UAE — availability is currently limited to those three markets starting June 2026. Third, ITC action on the Samsung complaint, which could either freeze a key competitor or boomerang into a settlement.
Additional coverage: EU Health Data Deal, FDA Wearables Guidance Force Apple, Google, Samsung to Rewire Data
FAQ
Sources include company disclosures, regulatory filings, analyst reports, and industry briefings.
Related Coverage
About the Author
David Kim
AI & Quantum Computing Editor
David focuses on AI, quantum computing, automation, robotics, and AI applications in media. Expert in next-generation computing technologies.
Frequently Asked Questions
When did Oura file for its IPO and at what valuation?
Oura confidentially filed a draft S-1 with the SEC on May 21, 2026. The filing follows a $900 million Series E in autumn 2025 that valued the Finnish company at approximately $11 billion. The number of shares and price range have not yet been set.
What's new in the Oura Ring 5?
The Ring 5 is 40% smaller than the Ring 4, adds Health Radar with Blood Pressure Signals and Nighttime Breathing, plus GLP-1 medication tracking, Health Records integration and live activity tracking. It starts at $399, with premium finishes at $499, and shipments began June 4, 2026.
Do Ring 4 owners need to upgrade to get the new features?
No. Oura is rolling Health Radar, Blood Pressure Signals, Nighttime Breathing, GLP-1 Insights and live activity tracking to Ring Gen 3 and later via a software update on June 4, 2026. The hardware upgrade is primarily about the smaller form factor and improved sensors.
Why is Samsung's Galaxy Ring 2 delayed?
Samsung is reportedly delaying the Galaxy Ring 2 until late 2026 or early 2027 amid an active patent dispute with Oura. Oura has filed a complaint with the US International Trade Commission requesting a sales ban on the current Galaxy Ring, and Samsung has filed counter-litigation.
How does Oura compare to other private wearable companies on valuation?
Whoop raised $575 million in Series G funding at a $10.1 billion valuation in March 2026. Oura's last private round valued it at $11 billion. Both signal strong private-market appetite for subscription-based health wearables ahead of broader IPO market activity.
